Lonza Group Ltd (SWX: LONN), the global life sciences company, announces that Lonza has granted UCB a non-exclusive, worldwide license to their GS Gene Expression SystemTM (GS: glutamine synthetase). The Research Evaluation Agreement covers the use of the GS Gene Expression SystemTM for research and development purposes.
